This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What's in Store for Virgin Galactic's (SPCE) Q4 Earnings?
by Zacks Equity Research
Virgin Galactic's (SPCE) Q4 earnings are expected to have been negatively impacted by the ongoing delays to its operations, leading to accumulated impacts on both schedule and cost efficiency.
Leidos Holdings (LDOS) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Leidos Holdings' (LDOS) revenues in the fourth quarter improve 10.1% year over year, backed by growth across its Defense Solutions and Civil segment.
Aerojet Rocketdyne (AJRD) Q4 Earnings Up Y/Y, Revenues Beat
by Zacks Equity Research
Aerojet Rocketdyne's (AJRD) fourth-quarter adjusted earnings improve 74.1% year over year, while GAAP EPS rises 43.3% on higher revenues.
FLIR Systems (FLIR) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
FLIR Systems' (FLIR) Q4 earnings are likely to have benefited from cost-saving initiatives. However, adverse impact of the pandemic on commercial aerospace might have hurt revenues.
4 Toxic Stocks That Could Ruin Your Portfolio
by Rimmi Singhi
Toxic stocks usually carry huge debt load and are vulnerable to external shocks. They should be timely discarded from one's portfolio to avoid wealth erosion.
What's in Store for Leidos Holdings (LDOS) in Q4 Earnings?
by Zacks Equity Research
Leidos Holdings' (LDOS) Q4 results are expected to benefit from recent acquisitions and solid execution of programs.
Huntington Ingalls (HII) Q4 Earnings Miss, Revenues Rise Y/Y
by Zacks Equity Research
Huntington Ingalls' (HII) Q4 revenues of $2,757 million surpass the Zacks Consensus Estimate by 11.8% and improve 14.3% year over year.
TransDigm's (TDG) Q1 Earnings Miss Estimates, Sales Down Y/Y
by Zacks Equity Research
TransDigm's (TDG) bottom line plunges 59.4% year over year in the fiscal first quarter, primarily reflecting a decline in net sales and higher interest expenses.
What's in Store for Huntington Ingalls (HII) in Q4 Earnings?
by Zacks Equity Research
Huntington Ingalls' (HII) Q4 results are expected to reflect revenue growth along with favorable earnings performance, driven by better cost management initiatives.
4 Defense Equipment Stocks to Watch as Air Traffic Gradually Improves
by Aparajita Dutta
Encouraging demand forecast for 2021 driven by vaccine rollout boosts the Aerospace-Defense Equipment industry's growth prospects. Stocks like CAE, TDG, BAESY and TGI remain the industry forerunners.
Triumph Group (TGI) Q3 Earnings Top Estimates, Sales Fall Y/Y
by Zacks Equity Research
Triumph Group's (TGI) organic sales in third-quarter fiscal 2021 fell 32% year over year owing to planned reductions in sunsetting and transitioned programs.
Beat Your Portfolio Fatigue by Dumping These Toxic Stocks
by Rimmi Singhi
Stocks without sturdy fundamentals are toxic for your portfolio. Identifying such bloated stocks accurately and dumping them at the right time can protect your returns.
L3Harris' (LHX) Q4 Earnings Beat Estimates, Revenues Fall Y/Y
by Zacks Equity Research
L3Harris' (LHX) revenues in the fourth quarter decrease 3.6% year over year, led by a decline in Aviation systems sales.
Northrop Grumman (NOC) Q4 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Northrop Grumman's (NOC) revenues in the fourth quarter grow 17% year over year, led by an increase in Aeronautics systems, Space Systems and Mission Systems sales.
Defense Stock Roundup: RTX, TDY Beat on Q4 Earnings, BA, GD Miss
by Aparajita Dutta
Mixed performance of the defense stocks in the trailing five trading sessions can be attributed to varied Q4 operational performance and the steep sell-off observed on Wall Street
General Dynamics (GD) Q4 Earnings Miss Estimates, Sales Down Y/Y
by Zacks Equity Research
General Dynamics' (GD) backlog at the end of the fourth quarter stands at $89.5 billion, up 2.9% year over year.
Teledyne Technologies (TDY) Q4 Earnings & Sales Beat Estimates
by Zacks Equity Research
Teledyne Technologies' (TDY) top line declines 3% year over year in the fourth quarter due to lower sales in all segments, except Engineered Systems.
L3Harris (LHX) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
L3Harris' (LHX) cost-management initiatives and operational efficiencies might have boosted its margins, thereby boosting its fourth-quarter earnings.
Lockheed Martin (LMT) Q4 Earnings & Sales Beat Estimates
by Zacks Equity Research
Lockheed Martin's (LMT) bottom line improves 20.6% year over year in the fourth quarter primarily due to higher sales and operating profit.
Hexcel (HXL) Reports Loss in Q4, Misses Revenue Estimates
by Zacks Equity Research
Hexcel Corporation's (HXL) fourth-quarter revenues witness a 47.6% decline year over year, primarily due to the impacts of the pandemic.
Hexcel (HXL) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Hexcel (HXL) delivered earnings and revenue surprises of 0.00% and -0.38%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
RTX or LMT: Which Defense Stock Will Deliver Better Q4 Earnings?
by Aparajita Dutta
In spite of recovery in global air traffic, lingering factors like lower delivery volumes and higher storage costs might have impacted Q4 performance of defense stocks like RTX and LMT
Zacks.com featured highlights include: Carrols Restaurant Group, Nuance Communications, Hexcel and Melco Resorts & Entertainment
by Zacks Equity Research
Zacks.com featured highlights include: Carrols Restaurant Group, Nuance Communications, Hexcel and Melco Resorts & Entertainment
These 4 Toxic Stocks Could Endanger Your Portfolio
by Rimmi Singhi
A toxic stock is basically one that trades at a price not supported by its fundamental strength. Identifying toxic stocks is imperative in shielding one's portfolio from massive losses.
Teledyne (TDY) Stock Up on Impressive Q4 Preliminary Results
by Zacks Equity Research
Teledyne (TDY) expects GAAP EPS for Q4 in the range of $3.16-$3.19, which reflects stark improvement from the prior guidance range.